Remote Audiometry Validation for Hearing Research

Remote Audiometry Matches Clinic Accuracy in Validation Study

A new study has validated the accuracy of a remote hearing test that patients can take at home. The research, led by Erin Robertson and colleagues at Regeneron Pharmaceuticals, found that results from the iPad-based Shoebox PureTest audiometer were statistically equivalent to those from conventional clinic-based audiometry at frequencies of 500, 1000, 2000, and 4000 Hz. This addresses a significant logistical hurdle in hearing health research and care.

Traditional audiometry requires patients to travel to a soundproof booth in a clinic. For clinical trials that track hearing changes over months or years, these repeated visits become a major burden. They increase costs, consume time, and can limit who is able to participate. The study team aimed to determine if a remote, tablet-based system could provide data reliable enough for research use.

How the Remote Hearing Test Was Evaluated

Robertson’s team evaluated the Shoebox PureTest in participants with a wide range of hearing sensitivity. Each participant underwent hearing assessment using both the remote technology and the conventional, gold-standard method. The core of the methodology was a direct comparison of the hearing thresholds—the quietest sounds a person can hear—obtained by each method at standard frequencies.

Beyond pure accuracy, the researchers assessed reliability and usability. Participants completed a user experience survey to report on the application’s ease of use and their overall satisfaction. This dual focus on technical performance and human factors was essential for judging the system’s real-world potential.

High Accuracy and High User Satisfaction

The findings, published in Scientific Reports, confirm the system’s validity. The Shoebox PureTest audiometer was “statistically equivalent” to conventional assessments at the critical speech-frequency range. This means the data it collects is accurate enough to be used in clinical research studies, potentially replacing in-clinic visits for routine threshold tracking.

The user feedback was strongly positive. More than 80% of users rated the application and its usability as ‘good’. The overall satisfaction score was even higher, with 92% of participants rating their experience as ‘excellent’. This high acceptance rate is vital for ensuring compliance in long-term studies where patients must perform tests independently at home.

The study authors note that while operational considerations for widespread trial use remain, the Shoebox PureTest “has been shown to be a valid alternative to conventional hearing assessments.” It is important to acknowledge that all authors are employees and shareholders of Regeneron Pharmaceuticals, Inc., the developer of the technology.

Implications for Hearing Disorder Research and Care

The validation of accurate remote audiometry has immediate practical implications. For clinical trials investigating treatments for tinnitus, hyperacusis, or hearing loss, this technology can optimize study design. It allows for more frequent monitoring of hearing thresholds without demanding extra clinic visits, potentially improving data quality and participant retention. This could accelerate research in areas like novel tinnitus treatment strategies or the links between hearing loss and other conditions.

Reducing the burden of participation also makes trials more accessible. Individuals who live far from research centers, have mobility issues, or have demanding schedules may now be able to take part. This can lead to more diverse and representative study populations.

In a broader clinical context, reliable remote testing could eventually support telehealth models for audiology. It enables clinicians to monitor patients with stable conditions or those undergoing long-term sound therapy for misophonia or hyperacusis from a distance. The convenience factor is substantial, as noted in related research on the importance of reducing lifestyle burdens for managing chronic conditions.

A Step Toward More Accessible Hearing Health

This study provides evidence that remote, self-administered hearing testing can meet the rigorous standards required for clinical research. The Shoebox PureTest system represents a shift toward decentralized trial models in hearing science. By removing geographic and logistical barriers to accurate assessment, it may help research move faster and reach more people.

As with any new tool, successful implementation will depend on clear instructions, technical support, and appropriate patient selection. However, the core finding stands: a tablet and calibrated headphones can now collect hearing data as accurately as a clinic booth for key metrics. This development is particularly relevant for the longitudinal study of hearing health and its intersection with patient well-being.

The research paper, “Validation of the Shoebox PureTest audiometry technology for remote data collection in clinical trials,” is available with its full details via DOI 10.1038/s41598-026-49550-8 (PMID: 42286011).